跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,487 条关于
“DLT”
全部
1,487
临床试验
955
药物
361
机构
13
资讯
158
5年前
FDA Grants Orphan Drug Status to Novel IRAK4 Inhibitor for AML and MDS Treatment
去年
Qilu Pharmaceutical's QLS32015 Shows Promise in Relapsed/Refractory Multiple Myeloma
去年
Backfill-QoL Design Integrates Quality of Life in Phase I Dose-Escalation Trials
10个月前
Erdafitinib Shows Promising Early Efficacy and Manageable Safety Profile in FGFR-TACC Fusion-Positive Glioma
去年
Allogeneic Power3 Knock-Out CAR-T Cell Therapy Shows Promise in Relapsed/Refractory B-ALL
2年前
Clarity Pharmaceuticals' 67Cu-SAR-bisPSMA Shows Promise in mCRPC Trial
去年
Novel CAR T-Cell Therapy Trial Advances to Third Cohort in Ovarian Cancer
10个月前
Aurigene's MALT1 Inhibitor AUR112 Shows 63.6% Response Rate in Phase 1 Lymphoma Trial
去年
Belantamab Mafodotin Combinations Show Promise in Japanese Patients with Relapsed/Refractory Multiple Myeloma
上个月
Dispatch Bio Doses First Patient in Phase 1 Trial of DISP-10, a Novel Synthetic-Antigen CAR T Immunotherapy for Advanced GI Cancers, Secures FDA Fast Track Designation
第 1 页,共 16 页
上一页
下一页